subscribeSubscribe
price-trendAsk Us
Clinigen notes results from the MIROCALS trial investigating low dose ProleukinÂ

Clinigen notes results from the MIROCALS trial investigating low dose ProleukinÂ
GLOBENEWSWIRE
08 Dec 2022
Share Share
Cancer drug could aid heart attack recovery

Cancer drug could aid heart attack recovery
FIRSTWORD PHARMA
06 Sep 2021
Share Share
Exelixis` Growth `Heavily` Depends on Success of Tumor Drugs Cabometyx, XL092

Exelixis` Growth `Heavily` Depends on Success of Tumor Drugs Cabometyx, XL092
PRESS RELEASE
19 Jul 2021
Share Share
Synthekine Launches with $82 Million Series A Financing to Advance Pipeline

Synthekine Launches with $82 Million Series A Financing to Advance Pipeline
BIOSPACE
17 Sep 2020
Share Share
Clinigen signs agreement with Iovance Biotherapeutics

Clinigen signs agreement with Iovance Biotherapeutics
PRESS RELEASE
14 Jan 2020
Share Share
Clinigen completes acquisition of US rights to Proleukin

Clinigen completes acquisition of US rights to Proleukin
BIOSPACE
02 Apr 2019
Share Share
Clinigen buys U.S. rights to Novartis` cancer drug Proleukin

Clinigen buys U.S. rights to Novartis` cancer drug Proleukin
Pushkala Aripaka REUTERS
13 Feb 2019
Share Share
Aldesleukin: CMDh Scientific conclusions & amendments to Product Info (EMA)

Aldesleukin: CMDh Scientific conclusions & amendments to Product Info (EMA)
EMA
25 Oct 2018
Share Share